Recombinant Lactobacillus casei Glucose-6-phosphate isomerase (PGI) refers to a genetically engineered form of the enzyme PGI (EC 5.3.1.9) expressed in L. casei, a probiotic bacterium. PGI catalyzes the reversible isomerization of glucose-6-phosphate (G-6-P) to fructose-6-phosphate (F-6-P), a critical step in glycolysis and gluconeogenesis. This modification enhances metabolic flexibility, allowing L. casei to optimize carbon flux for applications in biotechnology, probiotics, and industrial fermentation .
The pgi gene from L. casei BL23 was cloned and overexpressed using homologous recombination. The recombinant strain exhibited a 115% increase in lactate yield when grown on galactose compared to the wild type .
Functional validation confirmed that PGI activity directly influences intracellular sugar-phosphate levels, including reductions in G-6-P (25–59% of control) and increases in F-6-P (128% of control) .
Recombinant PGI operates optimally at 37°C and pH 7.0, aligning with L. casei's physiological conditions .
Overexpression of pgi doubled the growth rate of L. casei on lactose and galactose, demonstrating its role in alleviating metabolic bottlenecks .
Overexpression of pgi increased lactate production by 15% in galactose-fed cultures, highlighting its potential for industrial lactic acid production .
Recombinant L. casei PGI strains show improved survival and metabolic activity in the gut, with engineered strains persisting at 4.3 × 10<sup>5</sup> CFU/ml in the hindgut of animal models .
Enhanced sugar metabolism enables better competition against pathogens by altering gut microbiota composition (e.g., reducing Proteobacteria abundance) .
Carbon Flux Modulation: PGI overexpression redirects metabolic pathways to favor glycolysis, improving yields of lactate and other fermentation products .
Synergy with Other Enzymes: Coupling PGI with α-phosphoglucomutase (α-Pgm) optimizes lactose utilization, increasing growth rates by 19% .
Growth Rate Enhancement:
Transcriptional Regulation:
Immune Modulation:
While not directly linked to PGI, recombinant L. casei platforms (e.g., antigen-delivery systems) benefit from metabolic engineering to enhance mucosal adhesion and immune response .
Industrial Scale-Up: Leveraging PGI-overexpressing strains for high-efficiency lactate production in bioreactors.
Gut Microbiome Therapeutics: Engineering L. casei to deliver PGI-driven metabolic benefits in dysbiosis or metabolic disorders.
CRISPR-Cas9 Integration: Precise editing of pgi regulatory elements to fine-tune enzyme activity under varying substrate conditions .
KEGG: lcb:LCABL_12870
Phosphoglucose isomerase (Pgi) catalyzes the reversible isomerization of glucose-6-phosphate to fructose-6-phosphate, representing a critical junction in carbohydrate metabolism. In L. casei, Pgi plays a fundamental role in glycolysis and functions at a key branching point between anabolic and catabolic pathways. The enzyme significantly influences carbon flux through the glycolytic pathway, particularly at the glucose-6P intermediate level, which affects both energy production and biosynthetic processes. Studies have demonstrated that the physiological amount of Pgi activity is limited for L. casei growth on certain carbon sources, particularly lactose and galactose, indicating its metabolic importance .
The pgi gene encoding phosphoglucose isomerase activity in L. casei can be identified through genomic analysis and functional screening approaches. Researchers have successfully identified and cloned this gene from L. casei BL23. The methodology involves:
Genomic DNA extraction from L. casei cultures
PCR amplification using primers designed from conserved regions of known bacterial pgi genes
Cloning the amplified gene into appropriate expression vectors
Verification of functionality through complementation studies or enzyme activity assays
Sequence confirmation through Sanger sequencing
The cloned pgi gene can then be used for homologous overexpression studies to evaluate its functional impact on metabolism .
When investigating recombinant L. casei pgi, several controls are critical for robust experimental design:
Vector-only control (L. casei transformed with empty vector) to account for effects of the transformation process and vector backbone
Wild-type L. casei strain to establish baseline growth and metabolic parameters
Growth on different carbon sources (glucose, lactose, galactose) to evaluate substrate-specific effects
Time-course measurements to capture dynamic metabolic changes
Multiple biological and technical replicates to ensure statistical validity
For transformation experiments specifically, controls should include competent cells without plasmid DNA and cells transformed with a known functional plasmid to validate transformation efficiency .
Pgi overexpression in L. casei results in carbon source-dependent growth effects:
| Carbon Source | Growth Rate Effect | Notes |
|---|---|---|
| Glucose | Reduced glucose-6P levels (25% of control) | Increased fructose-6P levels (128% of control) |
| Lactose | Almost double growth rate | Glucose-6P reduced to 59% of control levels |
| Galactose | Almost double growth rate | UDP-glucose and UDP-galactose reduced to 66% and 55% respectively |
These findings demonstrate that the physiological amount of Pgi activity is a limiting factor for L. casei growth on lactose and galactose, and that limitation was overcome through pgi gene overexpression. The differential effects across carbon sources highlight the metabolic versatility and regulation of L. casei .
Pgi overexpression in L. casei induces significant changes in the intracellular concentrations of key metabolic intermediates:
Glucose-6P levels: Reduced to 25% of control strain when cultured in glucose, and 59% when cultured in lactose
Fructose-6P levels: Increased to 128% of control strain levels when cultured on glucose
UDP-glucose levels: Reduced to 66% of control strain levels when cultured on galactose
UDP-galactose levels: Reduced to 55% of control strain levels when cultured on galactose
These alterations in metabolite concentrations demonstrate the modulation capacity of carbon fluxes in L. casei at the level of the glycolytic intermediate glucose-6P, indicating that Pgi activity redirects carbon flow between anabolic and catabolic pathways .
Overexpression of pgi in L. casei results in increased lactate production, particularly when grown on galactose. Research has demonstrated that the lactate yield increased to 115% in the strain overproducing Pgi grown in galactose compared to control strains. This suggests that enhanced glucose-6-phosphate isomerase activity redirects carbon flux through glycolysis, ultimately increasing pyruvate availability for lactate production. The effect appears to be carbon source-dependent, highlighting the complex relationship between glucose-6-phosphate metabolism and fermentation end-products in L. casei .
Electroporation has proven to be the most effective transformation method for L. casei genetic modification. Based on published protocols, the optimal procedure includes:
Preparation of ice-cold competent L. casei cells (typically 1 × 10^8 CFU/mL)
Mixing plasmid DNA with competent cells
Transferring the mixture to a pre-cooled electroporation cuvette (0.2 cm interelectrode distance)
Applying a single electrical pulse at specific parameters (1.5 V, 25 μF)
Immediate recovery in specialized medium (e.g., MRS broth with 0.3 M sucrose)
Incubation at 37°C for 3-3.5 hours to allow expression of antibiotic resistance genes
Plating on selective media (e.g., MRS agar with appropriate antibiotic such as 10 μg/mL chloramphenicol)
Successful transformants can be verified through PCR, sequencing, and functional assays. This method has been effectively used for introducing various recombinant constructs into L. casei strains .
For effective pgi expression in L. casei, several vector design considerations are critical:
Origin of replication compatible with L. casei (typically derived from native L. casei plasmids)
Appropriate selection markers (chloramphenicol resistance genes are commonly used)
Promoter selection:
Constitutive promoters for continuous expression
Inducible promoters (such as the lactose operon) for controlled expression
Signal sequences:
Surface-display vectors for anchoring proteins to the cell wall
Secretion vectors for protein release into the extracellular environment
Integration vectors that facilitate recombination with the L. casei chromosome are particularly valuable for stable expression without antibiotic selection. For example, integration into the chromosomal lactose operon has been successfully employed, allowing gene expression to follow the same regulation pattern as the lac genes (repressed by glucose and induced by lactose) .
Verification of successful gene integration in recombinant L. casei strains requires a multi-faceted approach:
PCR verification:
Colony PCR using primers flanking the integration site
PCR amplification of the integrated gene with gene-specific primers
Sequencing confirmation:
Sanger sequencing of PCR products to confirm correct sequence and integration site
Whole genome sequencing for comprehensive verification
Functional validation:
Western blotting to confirm protein expression
Enzyme activity assays (e.g., Pgi activity measurements)
Metabolite analysis to detect changes in relevant compounds (glucose-6P, fructose-6P)
Stability testing:
Serial passaging without selection to confirm stable integration
PCR verification after multiple generations
These approaches collectively ensure the genetic modification has been successfully implemented and is functionally expressed in the recombinant strain .
For precise quantification of sugar-phosphate metabolites in recombinant L. casei strains, several analytical techniques are recommended:
Liquid Chromatography-Mass Spectrometry (LC-MS):
Provides high sensitivity for detection of sugar phosphates
Allows simultaneous measurement of multiple metabolites
Enables differentiation between isomeric compounds (e.g., glucose-6P vs. fructose-6P)
Nuclear Magnetic Resonance (NMR) spectroscopy:
13C-NMR analysis can track carbon flux through metabolic pathways
Provides structural information about metabolites
Can be used for real-time metabolic studies
Enzymatic assays:
Coupled enzyme assays specifically measuring glucose-6P or fructose-6P
Provides targeted, sensitive, and specific quantification
Sample preparation considerations:
Rapid quenching of metabolism (cold methanol or liquid nitrogen)
Efficient extraction protocols (perchloric acid or hot ethanol extraction)
Careful handling to prevent degradation of labile metabolites
These methods have successfully demonstrated that pgi overexpression in L. casei results in reduced glucose-6P levels (to 25-59% of control) and increased fructose-6P levels (to 128% on glucose) .
Analyzing carbon flux in pgi-modified L. casei requires sophisticated metabolic flux analysis techniques:
13C-metabolic flux analysis:
Growth on 13C-labeled substrates (e.g., [1-13C]glucose or [U-13C]glucose)
Analysis of isotope distribution in metabolic intermediates and end products
Mathematical modeling to determine flux distributions
Metabolomics approaches:
Comprehensive profiling of intracellular metabolites
Time-course measurements to capture dynamic changes
Correlation analysis between metabolite levels
Transcriptomic and proteomic analysis:
RNA-seq to measure gene expression changes
Proteomics to quantify enzyme abundance
Integration of multi-omics data for comprehensive pathway analysis
Enzyme activity measurements:
In vitro assays of key enzymes in related pathways
Determination of kinetic parameters (Km, Vmax)
Correlation between enzyme activities and metabolic flux
These approaches collectively provide a comprehensive understanding of how pgi modification alters carbon flow through central metabolic pathways in L. casei .
For accurate assessment of Pgi enzyme activity in recombinant L. casei strains, the following methodological considerations are important:
Cell preparation:
Harvesting cells in exponential growth phase
Careful cell lysis methods (sonication, mechanical disruption, or enzymatic lysis with lysozyme)
Preparation of cell-free extracts with appropriate buffer systems
Enzyme assay formats:
Spectrophotometric assays measuring NADPH production in a coupled system
Forward reaction: Glucose-6P → Fructose-6P (coupled with phosphofructokinase and aldolase)
Reverse reaction: Fructose-6P → Glucose-6P (coupled with glucose-6P dehydrogenase)
Assay optimization:
Determination of optimal pH, temperature, and buffer conditions
Linearity verification with respect to time and enzyme concentration
Inclusion of appropriate controls (heat-inactivated extracts, known standards)
Data analysis:
Calculation of specific activity (μmol/min/mg protein)
Determination of kinetic parameters (Km, Vmax)
Statistical analysis comparing different strains or growth conditions
These methods enable quantitative comparison of Pgi activity levels between wild-type and recombinant strains, confirming successful overexpression and correlating enzyme activity with observed metabolic changes .
Pgi-modified L. casei strains offer several promising avenues for metabolic engineering:
Enhanced production of valuable metabolites:
Redirecting carbon flux toward target compounds
Combining pgi modification with other genetic changes for synergistic effects
Fine-tuning glycolytic flux for optimal productivity
Strain optimization for industrial fermentations:
Improving growth rates on specific carbon sources
Enhancing substrate utilization efficiency
Developing strains with customized metabolic profiles
Probiotic applications:
Engineering strains with enhanced survival in the gastrointestinal tract
Developing strains that produce beneficial compounds in situ
Creating recombinant probiotics with specific health-promoting functions
Vaccine delivery vehicles:
Using L. casei as a vector for antigen delivery
Exploiting metabolic engineering to enhance immunogenicity
Developing oral vaccine candidates with improved efficacy
Knowledge of the role of key enzymes like Pgi in metabolic fluxes at branching points between anabolic and catabolic pathways allows for rational design of engineering strategies in L. casei for these various applications .
Integrating pgi modification with other genetic changes can create L. casei strains with enhanced functionality through several strategies:
Multi-enzyme pathway engineering:
Coordinated modification of multiple glycolytic enzymes
Combined overexpression of pgi with α-phosphoglucomutase (α-Pgm)
Engineering of branching pathways to direct flux toward desired products
Redox balance optimization:
Inactivation of L-lactate dehydrogenase gene combined with pgi overexpression
Engineering alternative NAD+ regeneration pathways
Creation of strains with modified NADH/NAD+ ratios for specific applications
Regulatory network modifications:
Engineering carbon catabolite repression systems
Modifying transcriptional regulators controlling pgi expression
Implementing synthetic regulatory circuits for dynamic control
Adaptive laboratory evolution:
Directed evolution of pgi-modified strains under selective pressure
Selection for improved growth or product formation
Identification of compensatory mutations that enhance phenotype
One particularly successful example combines pgi overexpression with L-lactate dehydrogenase inactivation, which leads to increased production of alternative products as the engineered route provides an alternative pathway for NAD+ regeneration .
Research on recombinant L. casei pgi faces several challenges that require innovative solutions:
Genetic stability issues:
Challenge: Loss of plasmid-based expression systems without selection pressure
Solution: Chromosomal integration strategies, such as integration into the lactose operon
Implementation: Using homologous recombination or CRISPR-Cas9 techniques for precise genomic integration
Expression level control:
Challenge: Achieving optimal expression levels for metabolic balance
Solution: Development of tunable promoter systems specific for L. casei
Implementation: Testing promoter libraries with varying strengths or inducible systems
Strain-specific variability:
Challenge: Different L. casei strains may respond differently to pgi modification
Solution: Comparative studies across multiple strains (e.g., BL23, KACC92338)
Implementation: Standardized protocols for cross-strain comparison
Metabolic burden of recombinant protein production:
Challenge: Overexpression may cause growth defects or metabolic imbalances
Solution: Fine-tuning expression levels and growth conditions
Implementation: Systematic optimization of culture conditions for each recombinant strain
Translation to in vivo applications:
Challenge: Laboratory performance may not predict functionality in actual applications
Solution: Development of relevant model systems for testing
Implementation: Testing recombinant strains in simulated gastrointestinal conditions or animal models
Addressing these challenges will require interdisciplinary approaches combining molecular biology, systems biology, and metabolic engineering techniques .
When evaluating recombinant L. casei pgi strains, comprehensive testing across multiple growth conditions is essential:
| Parameter | Recommended Conditions | Rationale |
|---|---|---|
| Carbon sources | Glucose, lactose, galactose | Different effects observed with pgi overexpression on different sugars |
| Growth media | MRS (standard), defined minimal media | Assess performance in both rich and defined environments |
| Temperature | 30°C, 37°C, 42°C | Evaluate temperature dependence of phenotype |
| pH | 5.5, 6.5, 7.5 | Assess pH tolerance and optimal growth conditions |
| Oxygen levels | Aerobic, microaerobic, anaerobic | Determine impact of oxygen on metabolic shifts |
| Growth phase | Lag, exponential, stationary | Capture temporal dynamics of metabolism |
Each condition should be tested with appropriate controls, including wild-type and empty vector strains. Time-course sampling is recommended to capture dynamic metabolic changes throughout growth. This comprehensive approach has revealed that pgi overexpression in L. casei results in different growth rates and metabolite profiles depending on the carbon source used .
Designing experiments to assess the survivability of recombinant L. casei requires consideration of both in vitro and in vivo conditions:
In vitro survival assessment:
Acid tolerance tests (pH 2.0-4.0 for varying time periods)
Bile salt resistance (0.1-0.5% bile salts)
Temperature stress (4°C storage, 50-55°C heat shock)
Simulated gastrointestinal transit (sequential exposure to artificial gastric juice and intestinal fluid)
Long-term storage stability at different temperatures
In vivo survival assessment:
Animal model studies with controlled feeding of recombinant strains
Time-course sampling from different intestinal segments
Quantification methods:
Selective plating with antibiotic markers
Strain-specific PCR for identification
Colony counts from intestinal samples
Data analysis and reporting:
Recovery rates expressed as CFU/ml or CFU/g of intestinal content
Statistical comparison between different intestinal segments
Persistence monitoring over multiple days
Published studies have successfully used these approaches to demonstrate that recombinant L. casei can effectively colonize intestinal environments, with quantifiable presence in the fore-, mid-, and hind-gut regions, showing particularly high numbers in the hind-gut (4.3 × 10^5 CFU/ml for surface-displayed constructs) .
For rigorous scientific investigation of pgi expression in L. casei, a comprehensive set of controls and replicate designs is essential:
Strain controls:
Wild-type L. casei (unmodified parent strain)
Empty vector control (transformed with vector backbone only)
Positive control (strain with known phenotype)
Multiple independently derived transformants of the same construct
Experimental controls:
No-template controls for PCR verification
Enzyme activity blanks and standards
Growth medium blanks
Heat-inactivated samples for enzyme assays
Replication strategy:
Minimum of three biological replicates (independent cultures)
Three technical replicates per biological replicate
Independent repetition of key experiments on different days
Validation approaches:
Multiple measurement techniques for critical parameters
Independent verification of key findings using alternative methods
Time-course measurements to ensure reproducibility across growth phases
Statistical analysis:
Appropriate statistical tests (t-tests, ANOVA, etc.)
Multiple testing correction where applicable
Effect size reporting in addition to p-values
This rigorous experimental design ensures that observed differences in growth rates, metabolite levels, or enzyme activities can be confidently attributed to pgi modification rather than experimental variability or artifacts .
Research on recombinant L. casei pgi has significant implications for microbiome studies through several interconnected dimensions:
Metabolic interactions:
Altered carbon metabolism in engineered L. casei may affect interactions with other microbiome members
Modified sugar utilization can influence competitive dynamics in mixed communities
Changes in metabolic end-products may serve as substrates for other microorganisms
Ecological considerations:
Engineered strains with enhanced growth capabilities may have altered colonization potential
Modification of key metabolic enzymes may affect niche adaptation
Persistence studies in complex environments help predict behavior in natural microbiomes
Functional capabilities:
Understanding metabolic engineering in L. casei provides insights into manipulating other microbiome members
Recombinant probiotics represent a potential approach for microbiome modulation
Metabolic studies in L. casei can serve as models for other lactic acid bacteria in microbiomes
Translational applications:
Engineered L. casei strains may serve as targeted probiotics for microbiome modulation
Knowledge of metabolic pathways enables rational design of synbiotic approaches
Understanding colonization dynamics informs strategies for successful microbiome interventions
These connections highlight how fundamental research on L. casei metabolism contributes to our broader understanding of microbiome function and manipulation strategies .
Research on pgi in L. casei offers several important insights for developing enhanced probiotic platforms:
Metabolic optimization:
Tailoring carbon metabolism for specific niches in the gastrointestinal tract
Engineering strains with enhanced survival through metabolic adaptations
Optimizing growth on available substrates in the intestinal environment
Functional enhancements:
Using pgi modification as part of larger metabolic engineering strategies
Combining metabolic optimization with delivery of bioactive compounds
Developing strains with enhanced competitive advantage against pathogens
Delivery system development:
Using metabolically engineered L. casei as delivery vehicles for antigens or therapeutic proteins
Optimizing expression systems for in situ production of beneficial compounds
Developing stable recombinant strains that maintain function without selection pressure
Safety considerations:
Understanding metabolic consequences of genetic modifications
Evaluating stability and containment of recombinant constructs
Assessing potential for horizontal gene transfer in complex environments
The L. casei KACC92338 strain has been identified as a potential probiotic candidate for producing functional fermented foods, health care products, and skin care products, highlighting the translational potential of this research .
Findings from L. casei pgi studies have broad implications for research on other lactic acid bacteria (LAB) through several mechanisms:
Methodological transfers:
Genetic engineering techniques optimized for L. casei can be adapted for other LAB
Analytical methods for metabolite quantification can be applied across species
Experimental designs for studying carbon metabolism are broadly applicable
Metabolic principles:
Understanding of glycolytic regulation through pgi may apply to related pathways in other LAB
Insights into carbon flux control points can inform metabolic engineering in diverse species
Strategies for redirecting metabolism toward valuable products may be transferable
Comparative genomics approaches:
Identification of conserved and divergent aspects of pgi function across LAB
Leveraging genomic information to predict metabolic capabilities in less-studied species
Understanding species-specific adaptations in central carbon metabolism
Biotechnological applications:
Development of expression systems that function across multiple LAB species
Creation of metabolic engineering toolkits with broad host range
Establishment of design principles for manipulating central carbon metabolism